| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.947279 |
| 003 | CaOODSP |
| 005 | 20250303105406 |
| 006 | m o d f |
| 007 | cr cn||||||||| |
| 008 | 250122t20252025onc ob f000 0 eng d |
| 020 | |a9780660753812 |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aH164-273/2025E-PDF |
| 245 | 00|aGuidance document : |bregulatory requirements for drug identification numbers (DINs). |
| 246 | 17|aRegulatory requirements for drug identification numbers (DINs) |
| 250 | |a[2025/02/18 edition]. |
| 264 | 1|aOttawa, Ontario : |bHealth Canada = Santé Canada, |c2025. |
| 264 | 4|c©2025 |
| 300 | |a1 online resource (21 pages) |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aCover title. |
| 500 | |a"Publication date: February 2025." |
| 500 | |a"Date adopted: 2019/05/03 ; Effective date: 2019/05/03 ; Administrative changes date: 2025/02/18." |
| 500 | |aIssued also in French under title: Ligne directrice : exigences réglementaires associées à une identification numérique attribuée à une drogue (DIN). |
| 504 | |aIncludes bibliographical references. |
| 650 | 0|aDrugs|xLabeling|zCanada. |
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
| 775 | 08|tLigne directrice : |w(CaOODSP)9.947280 |
| 795 | |tGuidance document : |b[2024/07/15 edition]|w(CaOODSP)9.939764 |
| 856 | 40|qPDF|s699 KB|uhttps://publications.gc.ca/collections/collection_2025/sc-hc/H164-273-2025-eng.pdf |
| 986 | |a240807 |